#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Neuroblastoma Cognitive disorder Hypoparathyroidism Granulomatosis with polyangiitis Breast angiosarcoma Ovarian cancer Colon cancer Fontan procedure Astrocytoma IPEX syndrome Neuroendocrine cell hyperplasia of infancy Glycogen storage disease type I Hyperchylomicronaemia Adrenocortical carcinoma More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy – Trials in Disease Mantle cell lymphoma stage II – Diagnostics Hairy cell leukaemia recurrent – Trials in Disease Alport’s syndrome Amyotrophic lateral sclerosis – Basic Information Hepatoblastoma – Life with Disease Richter’s syndrome – Diagnostics Prolymphocytic leukaemia Antisynthetase syndrome Hereditary hypophosphataemic rickets – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IADADEMSTAT ANTI-GD2-800CW Risdiplam Lovo-B Pemigatinib Evg321 Phenprocoumon Ecopipam Hydrochloride Cipaglucosidase Alfa Levetiracetam Mva-209-Fsp-B3 Lauromacrogol 400 Acetylcysteine Deferiprone Alxn1850 Sulodexide Odevixibat GSKVX000000040033 Rp-1664 Sulfate Ublituximab More therapies…

    Learn about Your Condition

    Endometrial cancer metastatic Cervix carcinoma Optic glioma Dupuytren's contracture Bartonellosis Polycystic liver disease Aplasia pure red cell Graves' disease Post-acute COVID-19 syndrome Shock T-cell lymphoma Advanced systemic mastocytosis Adenomatous polyposis coli Splenic marginal zone lymphoma Rectal adenocarcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Tulisokibart for Psoriatic Arthritis in Adults

    Recruiting

    2 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tulisokibart
    Germany Poland Spain

  • A study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1

    Recruiting

    3 1 1
    Investigated Drugs:
    • Humanised Igg1 Kappa Fragment Antibody Targeting Tfr1 Conjugated To P125 Oligonucleotide
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    Belgium Denmark France Germany Italy The Netherlands +1

  • Efficacy and tolerability of diclofenac potassium + thiocolchicoside versus diclofenac potassium in patients with acute severe low back pain

    Recruiting

    3 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • DICLOFENAC POTASSIUM
    • Thiocolchicoside
    • Paracetamol
    Cyprus Greece

  • Efficacy of intra‑articular allogeneic peripheral blood mononuclear cells induced to an early apoptotic state versus placebo in adults with primary knee osteoarthritis

    Recruiting

    2 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Allogeneic Peripheral Blood Mononuclear Cells Induced To An Early Apoptotic State
    Denmark Poland

  • A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Czechia France Germany Greece +4

  • A study to evaluate the safety and effectiveness of surlorian in adults with RYR1-related myopathy

    Recruiting

    2 1
    Investigated Diseases:
    • Congenital myopathy
    France Germany The Netherlands Spain
Previous Page
1 2 3 4 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!